F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on a
review of clinical records and the Resident Assessment Instrument and staff interviews, it was determined
that the facility failed to ensure that the Minimum Data Set Assessments (MDS - a federally mandated
standardized assessment conducted at specific intervals to plan resident care) accurately reflected the
status of one resident out of six sampled (Residents 1).
Residents Affected - Few
Findings include:
According to the RAI User's Manual, Section J1700, Fall History, items in this section assesses, prior fall
history, fractures from falls in the past month and prior to admission to the facility.
A review of Resident 1's admission MDS assessment dated [DATE], revealed that in section J1700 the
resident had no fall or fracture from a fall prior to admission to the facility in the last 2-6 months.
However, a review of hospital documentation revealed that the resident had a new thoracic-8 superior end
plate compression fracture from a fall at home on April 3, 2023.
Interview with the NHA (Nursing Home Administrator) on May 23, 2023, at approximately 2:30 PM
confirmed that Resident 1's MDS assessment was not accurate with respect to fall and fracture prior to
admission.
28 Pa. Code 211.5(g)(h) Clinical records
28 Pa. Code 211.12(c)(d)(1)(5) Nursing services
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
396074
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
396074
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Allied Services Skilled Nursing Center
303 Smallacombe Drive
Scranton, PA 18501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart,
following irregularity reporting guidelines in developed policies and procedures.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on a
review of clinical records and pharmacist drug regimen reviews and staff interview it was determined that
the pharmacist failed to identify an irregularity in the drug regimen of one resident (Resident A1) out of five
residents reviewed.
Findings include:
Regulatory guidance indicates that a drug irregularity includes, but is not limited to, use of medications
without adequate indication, without adequate monitoring, in excessive doses, and/or in the presence of
adverse consequences, as well as the identification of conditions that may warrant initiation of medication
therapy. The guidance further notes that a Medication Regimen Review (MRR) or Drug Regimen Review is
a thorough evaluation of the medication regimen of a resident, with the goal of promoting positive outcomes
and minimizing adverse consequences and potential risks associated with medication. The MRR includes
review of the resident's medical record in order to prevent, identify, report, and resolve medication-related
problems, medication errors, or other irregularities
A review of Resident A1's clinical record revealed that the resident was admitted to the facility on [DATE],
with diagnoses, which included hemiplegia (paralysis on one side of the body) and hemiparesis (weakness
on one side of the body) following stroke affecting left non-dominant side and hypertensive chronic kidney
disease (chronic kidney disease due to chronic high blood pressure).
A physician progress note completed upon the resident's admission to the facility revealed that the resident
was prescribed Metoprolol 25 mg twice a day for hypertension with a goal (to maintain the resident's blood
pressure) below 140/90. (Diastolic blood pressure is the pressure on the blood vessels when the heart
muscle relaxes. The diastolic pressure is always lower than the systolic pressure. Blood pressure is
measured in units of millimeters of mercury (mmHg). The readings are always given in pairs, with the upper
(systolic) value first, followed by the lower (diastolic) value).
Review of Resident 1's Medication Administration Records dated September 2022 through April 2023, and
clinical record revealed no documented evidence that the resident's blood pressure was monitored to
evaluate the effectiveness of the antihypertensive medication and to achieve the physician established goal
for the resident's blood pressure to be maintained below 140/90
A physician progress note dated April 25, 2023, indicated that the physician noted that the resident
complained of visual changes, difficulty reading, and experiencing a tension headache that would come
and go. The physician performed a physical exam, revealing that the blood pressure was 166/88, heart rate
was 75, and the resident was not in acute distress. The physician ordered an increase in the resident's
blood pressure medication. The entry noted that on April 25, 2023, the physician increased the resident's
Metoprolol (antihypertensive medication) to 50 mg two times per day with a blood pressure goal below
140/90.
Review of Resident A1's Medication Administration Record (MAR) and clinical record dated April 2023
revealed that there was no documented evidence that the resident's blood pressure was monitored to
evaluate the effectiveness of the increase in antihypertensive medication and that the resident's blood
pressure goal below 140/90 was met.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
396074
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
396074
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/03/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Allied Services Skilled Nursing Center
303 Smallacombe Drive
Scranton, PA 18501
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
A review of the monthly Medication Regimen Clinical Reviews conducted by the pharmacist from October
2022 through April 2023, revealed no indication that the pharmacist identified that the resident's blood
pressure was not being monitored in conjunction with the administration of antihypertensive medication to
meet the established goal for maintaining the resident's blood pressure below 140/90.
An interview with the Nursing Home Administrator and Director of Nursing on May 3, 2023, at
approximately 2:15 PM, confirmed that there was no documented evidence that the pharmacist had
identified the lack of blood pressure monitoring being conducted for Resident A1 in coordination with the
administration of the antihypertensive drug and established goal for maintaining the resident's blood
pressure levels.
28 Pa. Code 211.9 (k) Pharmacy services.
28 Pa. Code 211.12 (c) Nursing services.
28 Pa. Code 211.2(a) Physician services
28 Pa. Code 211.5(h) Clinical records
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
396074
If continuation sheet
Page 3 of 3